DHR vs XOM: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Exxon Mobil Corporation · Energy
$163.18
+10.3% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
XOM |
| Current Price |
$221.12 |
$163.18 |
| Fair Value Estimate |
$286.52 |
$179.98 |
| Upside to Fair Value |
+29.6%
|
+10.3%
|
| Market Cap |
$155.4B |
$676.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
9.9x
|
| Price / Sales |
6.2x
|
1.9x
|
| Price / FCF |
28.5x
|
22.3x
|
| Revenue Growth YoY |
+5.5%
|
+44.1%
|
| Gross Margin |
58.5%
|
25.1%
|
| Operating Margin |
20.4%
|
10.7%
|
| Return on Equity |
7.7%
|
12.7%
|
| Dividend Yield |
0.65% |
2.52% |
| FCF Yield |
3.51%
|
4.49%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Exxon Mobil is the largest integrated oil and gas major in the United States, operating across Upstream exploration and production, Downstream refining and fuels marketing, and Chemical manufacturing, with roughly 57,900 employees and a portfolio that spans conventional crude and natural gas, LNG, petrochemicals, and early-stage carbon capture, hydrogen, and biofuels ventures. The business qualit…
Accumulation Zones
| Metric |
DHR |
XOM |
| Zone Low |
$214.89 |
$134.98 |
| Zone High |
$243.54 |
$152.98 |
| In Buy Zone? |
Yes
|
No
|